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A process for isolating tissue-specific
progenitor cells exploits solid fat tissue
obtained as waste from such elective sur-
gical procedures as abdominoplasties
(“tummy tucks”) and breast reductions.
Until now, a painful and risky process of
aspiration of bone marrow has been
used to obtain a limited number of tis-
sue-specific progenitor cells. 
The present process yields more tissue-
specific progenitor cells and involves
much less pain and risk for the patient.
This process includes separation of fat
from skin, mincing of the fat into small
pieces, and forcing a fat saline mixture
through a sieve. The mixture is then di-
gested with collagenase type I in an incu-
bator. After centrifugation tissue-specific
progenitor cells are recovered and placed
in a tissue-culture medium in flasks or
Petri dishes. The tissue-specific progeni-
tor cells can be used for such purposes as
(1) generating three-dimensional tissue
equivalent models for studying bone loss
and muscle atrophy (among other defi-
ciencies) and, ultimately, (2) generating
replacements for tissues lost by the fat
donor because of injury or disease.
This work was done by Diane Byerly of
Johnson Space Center and Marguerite A. Sog-
nier of Universities Space Research Associa-
tion. Further information is contained in a
TSP (see page 1). MSC-23775-1
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hour incubations and 75 percent for 3-
hour incubations. Interestingly, sam-
ples incubated for less time (2 hours vs
3 hours) produced an increased per-
centage of antigen detection. Further
testing at incubation times such as 1
hour or lower could potentially in-
crease positive predictability based on
the study’s results. Also encouraging
were negative control experiments with
nonspecific antigens, beta galactosidase
and thyroglobulin, which showed re-
sults of 100 percent accuracy, with no
false positive detection.
This work was done by Maximilian C.
Scardelletti and Vanessa Varaljay of Glenn Re-
search Center. Further information is con-
tained in a TSP (see page 1).
Inquiries concerning rights for the commer-
cial use of this invention should be addressed
to NASA Glenn Research Center, Innovative
Partnerships Office, Attn: Steve Fedor, Mail
Stop 4–8, 21000 Brookpark Road, Cleve-
land, Ohio 44135. Refer to LEW-18387-1.
The ultimate goal of planetary protec-
tion research is to develop superior
strategies for inactivating resistance-
bearing micro-organisms like Rummeli -
bacillus stabekisii. By first identifying the
particular physiologic pathway and/or
structural component of the cell/spore
that affords it such elevated tolerance,
eradication regimes can then be de-
signed to target these resistance-confer-
ring moieties without jeopardizing the
structural integrity of spacecraft hard-
ware. Fur thermore, hospitals and gov-
ernment agencies frequently use biolog-
ical indicators to ensure the efficacy of a
wide range of sterilization processes.
The spores of Rummelibacillus stabekisii,
which are far more resistant to many of
such perturbations, could likely serve as
a more significant biological indicator
for potential survival than those being
used currently. 
Numerous surveys of the contami-
nant microbial diversity housed
within spacecraft assembly facilities
over the past six years have resulted
in the recurrent isolation of spore-
forming bacteria belonging to the
Bacillus genus. As Bacillus species are
capable of existing as metabolically
inactive, extremely hardy spores,
many lineages exhibit remarkable re-
silience to varying modes of biore-
duction/sterilization aimed at their
eradication (UV and gamma radia-
tion, oxidizing disinfectants, etc.).
The microorganism Rummelibacillus
stabekisii sp. nov. was isolated from the
surfaces of the cleanroom facility in
which the Mars Exploration Rovers
(MER) underwent assembly. This bac-
terium has not been previously re-
ported, and shows no close relation
to any previously described species
(as is assessed via 16S rRNA gene se-
quence comparison). This unique
isolate, and the Bacillus species most
genetically similar to it, were sub-
jected to a multitude of biochemical
tests in order to thoroughly charac-
terize its taxonomic position based
on physiological and phylogenetic ev-
idence. The results clearly show that
this bacterium is significantly differ-
ent from its nearest relatives.
The microbial colonization of space-
craft and cleanroom assembly facility
surfaces is of major concern to NASA
and others commissioning modern-day
space exploration. The search for life
elsewhere in the solar system will rely
heavily on validated cleaning and
sterility methods. It would be devastat-
ing to the integrity of a mission di-
rected at pristine environments such
as the Europa’s subsurface ocean or
the Martian polar caps to be compro-
mised as a result of terrestrial micro-
bial contamination. To this end, plane-
tary protection policies are in place to
ensure the cleanliness and sterility of
mission-critical spacecraft components
in order to prevent forward or back-
ward contamination.
Spores of Bacillus subtilis, a model
spore-forming laboratory strain that
demonstrates higher susceptibility to
ultraviolet and gamma radiation than
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other wild type spore formers, have
nevertheless been shown to survive up
to six years under interstellar space
conditions. Previously undescribed
spore-forming species, such as Rum-
melibacillus stabekisii, may exhibit even
greater resilience. It is in the best inter-
ests of NASA to thoroughly understand
the physiological capabilities of each
and every novel micro-organism iso-
lated from these spacecraft-associated
cleanrooms.
This work was done by Kasthuri
Venkateswaran, Myron T. La Duc, and
Parag A. Vaishampayan of Caltech for
NASA’s Jet Propulsion Laboratory. For more
information, contact iaoffice@jpl.nasa.gov.
NPO-46221.
Further Development of Scaffolds for Regeneration of Nerves 
Scale-up toward clinically significant dimensions has been partially completed. 
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Progress has been made in continuing
research on scaffolds for the guided
growth of nerves to replace damaged
ones. The scaffolds contain pores that are
approximately cylindrical and parallel,
with nearly uniform widths ranging from
tens to hundreds of microns. At the ear-
lier stage of development, experimental
scaffolds had been made from agarose
hydrogel. Such a scaffold was made in a
multistep process in which poly(methyl
methacrylate) [PMMA] fibers were used
as templates for the pores. The process
included placement of a bundle of the
PMMA fibers in a tube, filling the inter-
stices in the tube with a hot agarose solu-
tion, cooling to turn the solution into a
gel, and then immersion in acetone to
dissolve the PMMA fibers. The scaffolds
were typically limited to about 25 pores
per scaffold, square cross sections of no
more than about 1.5 by 1.5 mm, and
lengths of no more than about 2 mm.
To be clinically relevant, the scaffolds
must be scaled up: They are required to
have typical cross-sectional dimensions
of the order of 1 cm and to have lengths
in the approximate range of 2 to 2.5 cm.
For repairs of the central nervous sys-
tem, there is an additional requirement
that each scaffold contain between
about 100 and about 1,000 pores; for re-
pairs of peripheral nerves, there is a re-
quirement for sustained or timed re-
lease of brain-derived neurotrophic
factor (BDNF) or another suitable
nerve-growth agent to enable growth to
continue to the required lengths.
The work performed since the earlier
stage has been oriented toward satisfying
these and other requirements. The work
has included development of a more-
complex version of the prior multistep
process that has made it possible to
partly satisfy the scaling-up requirements
in that scaffolds having cross sections ex-
ceeding 1 cm2 in area and lengths up to
1 cm have been fabricated. One notable
feature of the present version of the
process is a multistep subprocess in
which a template of polystyrene (PS)
fibers is made from a composite of poly-
styrene fibers surrounded by a continu-
ous PMMA matrix. Another notable fea-
A Nerve-Growth Scaffold containing a reservoir of a nerve-growth agent would be attached to severed ends of a peripheral nerve.
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